Mallory A. Havens

1.4k total citations · 1 hit paper
14 papers, 1.1k citations indexed

About

Mallory A. Havens is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Mallory A. Havens has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Genetics. Recurrent topics in Mallory A. Havens's work include RNA modifications and cancer (5 papers), RNA Research and Splicing (5 papers) and MicroRNA in disease regulation (4 papers). Mallory A. Havens is often cited by papers focused on RNA modifications and cancer (5 papers), RNA Research and Splicing (5 papers) and MicroRNA in disease regulation (4 papers). Mallory A. Havens collaborates with scholars based in United States. Mallory A. Havens's co-authors include Michelle L. Hastings, Dominik M. Duelli, Geoffrey Weiner, Jaime Palma, Sarah Jeong, Patricio Meneses, Francine M. Jodelka, Kenneth R. Peterson, James P. Calvet and Scott A. Showalter and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mallory A. Havens

14 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Splice-switching antisense oligonucleotides as therapeutic drugs

2016 380 citations Mallory A. Havens, Michelle L. Hastings Nucleic Acids Research profile →

Peers

Countries citing papers authored by Mallory A. Havens

Since Specialization

Citations

This map shows the geographic impact of Mallory A. Havens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mallory A. Havens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mallory A. Havens more than expected).

Fields of papers citing papers by Mallory A. Havens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mallory A. Havens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mallory A. Havens. The network helps show where Mallory A. Havens may publish in the future.

Co-authorship network of co-authors of Mallory A. Havens

This figure shows the co-authorship network connecting the top 25 collaborators of Mallory A. Havens. A scholar is included among the top collaborators of Mallory A. Havens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mallory A. Havens. Mallory A. Havens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Elevating microRNA levels by targeting biogenesis with steric-blocking antisense oligonucleotides 2024 ·RNA ·Mallory A. Havens, Anthony J. Hinrich, Frank Rigo, Michelle L. Hastings	1
2	Sulfur-bridging the gap: investigating the electrochemistry of novel copper chelating agents for Alzheimer's disease applications 2023 ·JBIC Journal of Biological Inorganic Chemistry ·(unknown), (unknown), Mallory A. Havens, (unknown)	2
3	Copper Chelation via beta-alanine extends lifespan in a C. elegans model of Alzheimer's Disease 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mallory A. Havens	2
4	Interactions of copper and copper chelate compounds with the amyloid beta peptide: An investigation into electrochemistry, reactive oxygen species and peptide aggregation 2021 ·Journal of Inorganic Biochemistry ·(unknown), (unknown), (unknown), Mallory A. Havens, (unknown)	10
5	Strategic Design of Antimicrobial Hydrogels Containing Biomimetic Additives for Enhanced Matrix Responsiveness and HDFa Wound Healing Rates 2020 ·ACS Applied Bio Materials ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mallory A. Havens, Jason J. Keleher	5
6	A mutation affecting polycystin-1 mediated heterotrimeric G-protein signaling causes PKD 2018 ·Human Molecular Genetics ·Stephen C. Parnell, Brenda S. Magenheimer, Robin L. Maser, Tengis S. Pavlov, Mallory A. Havens, Michelle L. Hastings, (unknown), Christopher J. Ward, Kenneth R. Peterson, Alexander Staruschenko, James P. Calvet	30
7	Splice-switching antisense oligonucleotides as therapeutic drugs breakdown → 2016 ·Nucleic Acids Research ·Mallory A. Havens, Michelle L. Hastings	380
8	Drosha Promotes Splicing of a Pre-microRNA-like Alternative Exon 2014 ·PLoS Genetics ·Mallory A. Havens, (unknown), Michelle L. Hastings	42
9	Targeting SR Proteins Improves SMN Expression in Spinal Muscular Atrophy Cells 2014 ·PLoS ONE ·(unknown), Mallory A. Havens, Francine M. Jodelka, Michelle L. Hastings	46
10	Targeting RNA splicing for disease therapy 2013 ·Wiley Interdisciplinary Reviews - RNA ·Mallory A. Havens, Dominik M. Duelli, Michelle L. Hastings	135
11	Ensemble Analysis of Primary MicroRNA Structure Reveals an Extensive Capacity To Deform near the Drosha Cleavage Site 2013 ·Biochemistry ·Kaycee A. Quarles, Debashish Sahu, Mallory A. Havens, (unknown), (unknown), Michelle L. Hastings, Scott A. Showalter	19
12	MicroRNAs are exported from malignant cells in customized particles 2012 ·Nucleic Acids Research ·Jaime Palma, (unknown), (unknown), Mallory A. Havens, Sarah Jeong, Geoffrey Weiner, (unknown), (unknown), Michelle L. Hastings, Dominik M. Duelli	187
13	Biogenesis of mammalian microRNAs by a non-canonical processing pathway 2012 ·Nucleic Acids Research ·Mallory A. Havens, (unknown), Dominik M. Duelli, Michelle L. Hastings	162
14	Human Papillomavirus Type 16 Infection of Human Keratinocytes Requires Clathrin and Caveolin-1 and Is Brefeldin A Sensitive 2009 ·Journal of Virology ·(unknown), (unknown), Mallory A. Havens, Patricio Meneses	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact